Cagrilintide is a synthetic research peptide studied as a long-acting amylin receptor agonist — a mechanism distinct from the GLP-1, GIP, and glucagon receptor pathways targeted by compounds like semaglutide, GLP-1TRZ, and GLP-3RTA. Developed originally by Novo Nordisk, cagrilintide has drawn significant research interest both as a standalone amylin analog and as the amylin component of CagriSema, a fixed-dose combination studied alongside semaglutide in the REDEFINE clinical trial program. Helix Bio supplies Cagrilintide as a lyophilized powder intended strictly for laboratory and preclinical research, manufactured to a high-purity standard and backed by third-party verification. It is not intended for human consumption, diagnostic use, or any therapeutic application.
HPLC certified
Independent analysis
Highest standard
Full traceability
Cagrilintide is studied as an acylated analog of amylin, a hormone co-secreted with insulin that plays a role in satiety and gastric emptying. Unlike the GLP-1-class peptides that dominate current metabolic research, cagrilintide works through amylin receptor pathways in the brainstem rather than the GLP-1 receptor. That different mechanism is exactly why researchers study it both on its own and in combination with GLP-1 agonists like semaglutide — the two pathways are investigated for complementary rather than overlapping effects.
Helix Bio's Cagrilintide is supplied as a lyophilized (freeze-dried) powder — a synthetic peptide manufactured under controlled laboratory conditions. Lyophilization extends shelf stability prior to reconstitution, which is useful for labs running studies over an extended timeline rather than using a full vial at once.
This product exists to support in vitro and preclinical laboratory research only. It's manufactured, labeled, and sold for research use only (RUO) — not for human or veterinary use, not for diagnostic procedures, and not for compounding. It's intended for researchers studying amylin receptor pharmacology, appetite-regulation signaling, or comparative metabolic research models.
Amylin-pathway research is a smaller, more specialized corner of metabolic science than GLP-1 research, which makes sourcing quality material even more important — there's less published literature to cross-check a bad batch against. Helix Bio manufactures its Cagrilintide domestically, backs every batch with purity testing, and issues documentation so researchers can evaluate what they're working with before it reaches the bench. If your protocol calls for an amylin receptor agonist to study alongside or against a GLP-1 compound, that's what this listing is built around.
This product is not intended for individual consumers seeking to use it outside a research setting.
| Field | Detail |
|---|---|
| Product Name | Cagrilintide |
| Category | Research Peptide — Long-Acting Amylin Receptor Agonist |
| Form | Lyophilized powder |
| Purity | High-purity, batch-verified — see current lot's Certificate of Analysis for the exact figure |
| Appearance | White to off-white lyophilized powder |
| Storage (unreconstituted) | Store frozen, protected from light |
| Packaging | Sealed glass vial, tamper-evident packaging |
| Research Use | Laboratory / in vitro / preclinical research only — not for human or animal use |
| Manufacturer | Domestically produced (USA) |
| Quality | Third-party purity testing performed per batch |
| Lot Testing | HPLC and mass spectrometry verification |
| Country of Origin | United States |
Cagrilintide is studied across a few overlapping areas of metabolic and endocrine research:
As of mid-2026, cagrilintide's Phase 3 REDEFINE program has published results both for cagrilintide monotherapy and for the CagriSema combination, with a regulatory submission for CagriSema under FDA review. Cagrilintide itself remains an investigational compound — it is not FDA-approved as a standalone product and is not available by prescription. Everything sold by Helix Bio is intended for laboratory research only, not for administration to humans or animals outside a licensed research setting.
Purity is the first thing serious researchers check, and it's the first thing worth being transparent about. Helix Bio's Cagrilintide is manufactured in a controlled laboratory environment and tested by a third party using high-performance liquid chromatography (HPLC) and mass spectrometry — the two standard methods for confirming peptide identity and purity in the research supply chain. Each batch is issued its own Certificate of Analysis (COA), so purity isn't something you have to take on faith; you can review the documentation for the specific lot you receive. If a vendor can't produce a COA for the batch in your hand, that's worth treating as a red flag — for Cagrilintide or any research peptide.
Handling in our facility follows accepted good manufacturing practice for research-use compounds: peptides are processed to limit contamination, packaged in sealed, tamper-evident vials, and shipped in a way that protects the lyophilized powder from temperature swings and light exposure during transit.
Cagrilintide ships in a sealed, tamper-evident vial packaged to protect the lyophilized powder in transit. Because peptide stability can be affected by heat, orders are packed with insulation appropriate to the season and route. Exact carriers, transit times, and packaging materials can vary by order — check Helix Bio's shipping policy page for current specifics before ordering.
Cagrilintide sold by Helix Bio is intended strictly for in vitro laboratory and preclinical research use. It is not a drug, dietary supplement, cosmetic, or food product, and it is not approved by the FDA or any regulatory body for human or veterinary use, diagnosis, treatment, cure, or prevention of any disease or condition. This product must not be administered to humans or animals outside of a properly licensed research facility. Nothing on this page constitutes medical advice, and no statement here should be interpreted as a therapeutic or health claim. References to CagriSema and published clinical trial programs are provided for research and educational context only and do not imply that Helix Bio's Cagrilintide is the same product, formulation, or dosage as any investigational or approved drug product. By purchasing this product, the buyer confirms they are a qualified researcher, laboratory, or institution acquiring it for lawful research purposes only, and accepts full responsibility for compliance with all applicable local, state, and federal regulations governing research chemicals.
Knowledge Base
Knowledge Base
Knowledge Base
Knowledge Base
Knowledge Base
Knowledge Base
Knowledge Base
Knowledge Base
Knowledge Base
Knowledge Base
What bacteriostatic water contains, how it differs from sterile water and saline, where the 28-day opened-vial figure comes from, and what a COA can show.
Do you need a prescription for peptides? It depends on the category. See which peptides need one, which do not, and the dated 2026 FDA rules that apply.
The complete 2026 list of FDA-approved peptides: 47 drugs by category and approval year, which popular peptides are not approved, and pipeline to watch.
